Late-Onset Neutropenia After Rituximab Treatment

Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma

(2009) Gillianne Geet Yi Lai et al.   AMERICAN JOURNAL OF HEMATOLOGY

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis

(2009) Rachel B. Jones et al.   ARTHRITIS AND RHEUMATISM

Late Onset Neutropenia and Immunoglobulin Suppression of the Patients with Malignant Lymphoma Following Autologous Stem Cell Transplantation with Rituximab

(2009) Yasuo Hirayama et al.   INTERNAL MEDICINE

Immunoglobulin G Fc Receptor FcγRIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma

(2009) Wen-Kai Weng et al.   JOURNAL OF CLINICAL ONCOLOGY

The late adverse events of rituximab therapy – rare but there!

(2009) Ron Ram et al.   LEUKEMIA & LYMPHOMA

Late-onset neutropenia following viral bone marrow depression after rituximab therapy

(2008) Maximilian Christopeit et al.   ANNALS OF HEMATOLOGY

Organizing pneumonia associated with rituximab: Challenges raised by establishing causality

(2008) Huguette Lioté   JOINT BONE SPINE

Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia

(2008) K Stamatopoulos et al.   LEUKEMIA

Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis

(2008) Daniel Tesfa et al.   MEDICAL ONCOLOGY

Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias

(2007) Aarati Rao et al.   PEDIATRIC BLOOD & CANCER